Tc Biopharm Ltd (TCBP)

$1.16

Market is closed - opens 7 PM, 23 May 2024

Insights on Tc Biopharm Ltd

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 58.5% return, outperforming this stock by 151.3%

Performance

  • $1.13
    $1.20
    $1.16
    downward going graph

    2.59%

    Downside

    Day's Volatility :5.83%

    Upside

    3.33%

    downward going graph
  • $0.85
    $200.00
    $1.16
    downward going graph

    26.72%

    Downside

    52 Weeks Volatility :99.57%

    Upside

    99.42%

    downward going graph

Returns

PeriodTc Biopharm LtdIndex (Russel 2000)
3 Months
-4.92%
0.0%
6 Months
-88.4%
0.0%
1 Year
-92.85%
0.0%
3 Years
-99.95%
-20.1%

Highlights

Market Capitalization
5.4M
Book Value
$1.05
Earnings Per Share (EPS)
-19.31
Wall Street Target Price
140.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-108.92%
Return On Equity TTM
-556.68%
Revenue TTM
2.9M
Revenue Per Share TTM
29.64
Quarterly Revenue Growth YOY
188.6%
Gross Profit TTM
3.8M
EBITDA
-12.9M
Diluted Eps TTM
-19.31
Quarterly Earnings Growth YOY
-0.87
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Tc Biopharm Ltd(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 11968.97%

Current $1.16
Target $140.00

Technicals Summary

Sell

Neutral

Buy

Tc Biopharm Ltd is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tc Biopharm Ltd
Tc Biopharm Ltd
-26.58%
-88.4%
-92.85%
-99.95%
-99.95%
Moderna, Inc.
Moderna, Inc.
37.56%
83.82%
13.37%
-12.47%
553.14%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
10.42%
24.29%
32.26%
98.6%
210.52%
Novo Nordisk A/s
Novo Nordisk A/s
7.9%
30.89%
58.53%
230.87%
458.51%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
10.52%
25.13%
30.01%
109.26%
156.43%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tc Biopharm Ltd
Tc Biopharm Ltd
NA
NA
NA
0.0
-5.57
-1.09
NA
1.05
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-6.46
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
29.16
29.16
1.46
44.2
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.83
45.83
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
28.9
28.9
0.53
17.11
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tc Biopharm Ltd
Tc Biopharm Ltd
Buy
$5.4M
-99.95%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$54.0B
553.14%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.8B
210.52%
29.16
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$592.1B
458.51%
45.83
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$115.1B
156.43%
28.9
39.46%

Institutional Holdings

  • Armistice Capital, LLC

    3.05%
  • Tower Research Capital LLC

    0.11%
  • Citadel Advisors Llc

    0.03%

Company Information

Organization
Tc Biopharm Ltd
Employees
41
CEO
Mr. Bryan L. Kobel
Industry
Miscellaneous

FAQs